The role of adrenergic and cholinergic receptors on the antinociception of sildenafil in the spinal cord of rats

Neuroscience Letters

Volumn 502, Issue 2, 2011, Pages 99-102

  Park, Chen Hee ^a   Lee, Hyung Gon ^b   Lee, Seong Heon ^b   Chung, Cheol Won ^b   Yoon, Myung Ha ^b  

^a Gwangju Christian Hospital   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Acetylcholine; Adrenoceptors; Antinociception; Sildenafil; Spinal cord

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR; CYCLIC GMP; FORMALDEHYDE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; PHOSPHODIESTERASE V; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL RAT; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SUBARACHNOID SPACE;

ANIMALS; MALE; NOCICEPTORS; PIPERAZINES; PURINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SPINAL CORD; SULFONES;

EID: 80051807485     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.07.030     Document Type: Article

References (30)

1. Araiza-Saldana C.I., Reyes-Garcia G., Bermudez-Ocana D.Y., Francisca Perez-Severiano F., Granados-Soto V. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats. Eur. J. Pharmacol. 2005, 527:60-70.
2. Asomoza-Espinosa R., Alonso-Lopez R., Mixcoatl-Zecuatl T., Aguirre-Banuelos P., Torres-Lopez J.E., Granados-Soto V. Sildenafil increases diclofenac antinociception in the formalin test. Eur. J. Pharmacol. 2001, 418:195-200.
3. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 1995, 75:725-748.
4. Beavo J.A., Reifsnyder D.H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends. Pharmacol. Sci. 1990, 11:150-155.
5. Bezerra M.M., Lima V., Girão V.C.C., Teixeira R.C., Graça J.R.V. Antinociceptive activity of sildenafil and adrenergic agents in the writhing test in mice. Pharmacol. Rep. 2008, 60:339-344.
6. Boolell M., Gepi-Attee S., Gingell J.C., Allen M.J. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br. J. Urol. 1996, 78:257-261.
7. Brink C.B., Clapton J.D., Eagar B.E., Harvey B.H. Appearance of antidepressant like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies. J. Neural. Transm. 2008, 115:17-125.
8. Ferreira S.H., Nakamura M. Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins 1979, 18:179-190.
9. Guevara-Guzman R., Emson P.C., Kendrick K.M. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem. 1994, 62:7-810.
10. Huang L.J., Yoon M.H., Choi J.I., Kim W.M., Lee H.G., Kim Y.O. Effect of sildenafil on neuropathic pain and hemodynamics in rats. Yonsei Med. J. 2010, 51:82-87.
11. Jain N.K., Patil C.S., Singh A., Kulkarni S.K. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res. 2001, 909:170-178.
12. Jones P.G., Dunlop J. Targeting the cholinergic system as a therapeutic strategy for the treatment of pain. Neuropharmacology 2007, 53:197-206.
13. Kim W.M., Yoon M.H., Lee H.G., Han Y.G., Kim Y.O., Huang L.J., Cui J.H. GABAB receptor modulation on the antinociception of intrathecal sildenafil in the rat formalin test. Korean J. Pain 2007, 20:106-110.
14. Lee H.G., Kim W.M., Choi J.I., Yoon M.H. Roles of adenosine receptor subtypes on the antinociceptive effect of sildenafil in rat spinal cord. Neurosci. Lett. 2010, 480:182-185.
15. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart R., Park J., Schulz S., Chepenik K.P., Waldman S.A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 2000, 52:375-414.
16. Nakamizo T., Kawamata J., Yoshida K., Kawai Y., Kanki R., Sawada H., Kihara T., Yamashita H., Shibasaki H., Akaike A., Shimohama S. Phosphodiesterase inhibitors are neuroprotective to cultured spinal motor neurons. J. Neurosci. Res. 2003, 71:85-495.
17. Patil C.S., Jain N.K., Singh V.P., Kulkarni S.K. Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception. Indian J. Exp. Biol. 2004, 42:361-367.
18. Pertovaara A. Noradrenergic pain modulation. Progr. Neurobiol. 2006, 80:53-83.
19. Pyne N.J., Arshavsky V., Lochhead A. cGMP signal termination. Biochem. Soc. Trans. 1996, 24:1019-1022.
20. Romero T.R., Duarte I.D. alpha(2)-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the l-arginine/nitric oxide/cyclic GMP pathway in rat. Eur. J. Pharmacol. 2009, 613:64-67.
21. Sousa A.M., Prado W.A. The dual effect of a nitric oxide donor in nociception. Brain Res. 2001, 897:9-19.
22. Tegeder I., Schmidtkoa A., Niederberger E., Ruth P., Geisslinger G. Dual effects of spinally delivered 8-bromo-cyclic guanosine mono-phosphate (8-bromo-cGMP) in formalin-induced nociception in rats. Neurosci. Lett. 2002, 332:146-150.
23. Terrett N.K., Bell A.S., Brown D., Ellois P. Sildenafil (Viagra™), a potent and selective inhibitor of type 5 cGMP phospodiesterase with utility for the treatment of male erectile dysfunction. Bioorg. Med. Chem. Lett. 1996, 6:1819-1824.
24. Uckert S., Hedlund P., Andersson K.E., Truss M.C., Jonas U., Stief C.G. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur. Urol. 2006, 50:1194-1207.
25. Vale M.L., Rolim D.E., Cavalcante I.F., Ribeiro R.A., Souza M.H. Role of NO/cGMP/K(ATP) pathway in antinociceptive effect of sildenafil in zymosan writhing response in mice. Inflamm. Res. 2007, 56:83-88.
26. Vente J.D., Ittersum M.M., Vles J.S. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord. J. Chem. Neuroanat. 2006, 276:275-303.
27. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 1976, 17:1031-1036.
28. Yoon M.H., Choi J.I., Jeong S.W. Antinociception of intrathecal cholinesterase inhibitors and cholinergic receptors in rats. Acta Anaesthesiol. Scand. 2003, 47:1079-1084.
29. Yoon M.H., Kim W.M., Lee H.G., Kim Y.O., Huang L.J., An T.H. Roles of opioid receptor subtypes on the antinociceptive effect of intrathecal sildenafil in the formalin test of rats. Neurosci. Lett. 2008, 441:125-128.
30. Yoon M.H., Kim C.M., Lee H.G., Kim W.M., An T.H., Kim Y.O., Huang L.J. Synergistic antinociception of intrathecal sildenafil with clonidine in the rat formalin test. Pharmacol. Biochem. Behav. 2009, 92:583-588.